Bank of America’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-100
Closed -$1K 8181
2021
Q3
$1K Buy
+100
New +$1.22K ﹤0.01% 7958

Other funds holding ALT

Bank of America's ALT Position: Q1 2026 in Review

Bank of America increased its Altimmune (ALT) stake by 49% in Q1 2026, buying an estimated $792K and bringing the position to 570,203 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #4201.

Bank of America first reported a position in ALT in Q2 2014 and has held it in 39 quarters since. The position peaked at $8.71M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Bank of America held 570,203 shares of Altimmune worth $1.76M as of Q1 2026.
  • Bank of America bought 186,420 Altimmune shares in Q1 2026, an estimated $792K.
  • Altimmune made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4201 holding.
  • Bank of America first reported a position in Altimmune in Q2 2014 and has held it in 39 quarters since.
  • Bank of America's Altimmune position peaked at $8.71M in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.